Biopharmas raising money in public or private financings, including: 4D Molecular, Aveo Oncology, Cardiff Oncology, Celldex, Chemocentryx, Corat, Greenlight Biosciences, Medincell, Noxxon, Oncolytics, Portage Biotech, Therapeutics Acquisition, Royalty Pharma, Yumab.